The Growing Mpox Infections by Clade I Variant in African Countries Is a Public Health Emergency of International Concern: A Narrative Review

非洲国家I型变异株引起的痘病毒感染日益增多,构成国际关注的突发公共卫生事件:叙述性综述

阅读:1

Abstract

BACKGROUND AND AIM: In 2022, the monkeypox (mpox) outbreak was declared a public health emergency of international concern. The emergence of a new strain in the Democratic Republic of the Congo and its identification with neighboring countries led to the declaration of a public health emergency in 2024. The objective is to focus on the recent outbreak that led to its declaration as a Public Health Emergency of International Concern, assess the significant global public health threat posed by the newly identified class, and explore effective strategies to address this situation. METHODS: The present review searched information from databases (PubMed and Scopus), WHO, and the European Centre for Disease Prevention and Control. The search methods followed database-specific criteria. Key terms included mpox, prevalence, public health emergency, treatment, new variant, prevention, and strategy. We reviewed and extracted information from the relevant literature. RESULTS: Mpox has been endemic in the Democratic Republic of the Congo for over a decade, with a consistent annual rise in reported cases. In August 2024, at least 13 African countries have confirmed 2,863 cases and 517 fatalities. The recent emergence and transmission of a new strain, which appears to be predominantly spreading through sexual networks, along with its identification in neighboring countries, raises significant concerns for public health. CONCLUSION: The emergence of the new clade of mpox represents a critical public health challenge that necessitates immediate and coordinated global response efforts. By addressing the current outbreak comprehensively, we can mitigate its impact and safeguard public health across affected regions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。